Correlation Between XTL Biopharmaceutica and Clal Insurance

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both XTL Biopharmaceutica and Clal Insurance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XTL Biopharmaceutica and Clal Insurance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XTL Biopharmaceuticals and Clal Insurance Enterprises, you can compare the effects of market volatilities on XTL Biopharmaceutica and Clal Insurance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XTL Biopharmaceutica with a short position of Clal Insurance. Check out your portfolio center. Please also check ongoing floating volatility patterns of XTL Biopharmaceutica and Clal Insurance.

Diversification Opportunities for XTL Biopharmaceutica and Clal Insurance

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between XTL and Clal is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding XTL Biopharmaceuticals and Clal Insurance Enterprises in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Insurance Enter and XTL Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XTL Biopharmaceuticals are associated (or correlated) with Clal Insurance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Insurance Enter has no effect on the direction of XTL Biopharmaceutica i.e., XTL Biopharmaceutica and Clal Insurance go up and down completely randomly.

Pair Corralation between XTL Biopharmaceutica and Clal Insurance

Assuming the 90 days trading horizon XTL Biopharmaceuticals is expected to generate 6.0 times more return on investment than Clal Insurance. However, XTL Biopharmaceutica is 6.0 times more volatile than Clal Insurance Enterprises. It trades about 0.06 of its potential returns per unit of risk. Clal Insurance Enterprises is currently generating about 0.09 per unit of risk. If you would invest  400.00  in XTL Biopharmaceuticals on August 29, 2024 and sell it today you would earn a total of  240.00  from holding XTL Biopharmaceuticals or generate 60.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

XTL Biopharmaceuticals  vs.  Clal Insurance Enterprises

 Performance 
       Timeline  
XTL Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XTL Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Clal Insurance Enter 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Clal Insurance Enterprises are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Clal Insurance sustained solid returns over the last few months and may actually be approaching a breakup point.

XTL Biopharmaceutica and Clal Insurance Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with XTL Biopharmaceutica and Clal Insurance

The main advantage of trading using opposite XTL Biopharmaceutica and Clal Insurance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XTL Biopharmaceutica position performs unexpectedly, Clal Insurance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Insurance will offset losses from the drop in Clal Insurance's long position.
The idea behind XTL Biopharmaceuticals and Clal Insurance Enterprises pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing